QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article OPEN ACCESS ARTICLE Full Text Full Text (PDF) Supplemental Research Data Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Google Scholar Articles by Kaplan, D. D. Articles by Scott, M. P. PubMed PubMed Citation Articles by Kaplan, D. D. Articles by Scott, M. P. Related Content Related Article Social Bookmarking                   What's this?

A nucleostemin family GTPase, NS3, acts in serotonergic neurons to regulate insulin signaling and control body size

¹ Departments of Developmental Biology, Genetics, and Bioengineering, Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, California, 94305, USA; ² Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, California, 94305, USA

Growth and body size are regulated by the CNS, integrating the genetic developmental program with assessments of an animal’s current energy state and environmental conditions. CNS decisions are transmitted to all cells of the animal by insulin/insulin-like signals. The molecular biology of the CNS growth control system has remained, for the most part, elusive. Here we identify NS3, a Drosophila nucleostemin family GTPase, as a powerful regulator of body size. ns3 mutants reach <60% of normal size and have fewer and smaller cells, but exhibit normal body proportions. NS3 does not act cell-autonomously, but instead acts at a distance to control growth. Rescue experiments were performed by expressing wild-type ns3 in many different cells of ns3 mutants. Restoring NS3 to only 106 serotonergic neurons rescued global growth defects. These neurons are closely apposed with those of insulin-producing neurons, suggesting possible communication between the two neuronal systems. In the brains of ns3 mutants, excess serotonin and insulin accumulate, while peripheral insulin pathway activation is low. Peripheral insulin pathway activation rescues the growth defects of ns3 mutants. The findings suggest that NS3 acts in serotonergic neurons to regulate insulin signaling and thus exert global growth control.

[Keywords: Nucleostemin; serotonin; insulin; neurons; growth; size]

Received March 6, 2008; revised version accepted May 23, 2008.

E-MAIL mscott{at}stanford.edu; FAX (650) 725-2952.

Supplemental material is available at http://www.genesdev.org.

Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.1670508.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article

Serotonin and insulin signaling team up to control growth in Drosophila

Anne-Françoise Ruaud and Carl S. Thummel
Genes & Dev. 2008 22: 1851-1855. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

				A.-F. Ruaud and C. S. Thummel Serotonin and insulin signaling team up to control growth in Drosophila Genes & Dev., July 15, 2008; 22(14): 1851 - 1855. [Abstract] [Full Text] [PDF]